I just watched a Noridian webinar on the Medicare Quarterly Updates and this topic came up.
Medicare Physician Fee Schedule Final Rule Summary: CY 2023:
"Expansion of Coverage for Colorectal Cancer Screening and Reducing Barriers
For CY 2023, we’re modifying our policies to expand coverage of colorectal cancer (CRC) screening in 2 ways:
• First, we’re modifying coverage and payment requirements for certain CRC screening tests to start when the individual is 45 years of age or older, including Blood-based Biomarker Tests, The Cologuard™ – Multi-target Stool DNA (sDNA) Test, Immunoassaybased Fecal Occult Blood Test (iFOBT), Guaiac-based Fecal Occult Blood Test (gFOBT), MLN Matters: MM12982 Related CR 12982 Page 4 of 7 Barium Enema Test, and Flexible Sigmoidoscopy Test. Screening Colonoscopy will continue with no minimum age limitation. We aren’t modifying existing maximum age limitations.
• Second, we’re expanding the regulatory definition of CRC screening tests to include a follow-on screening colonoscopy after a Medicare covered non-invasive stool-based CRC screening test returns a positive result. We added the regulatory definition to 42 CFR 410.37.
See MLN Matters Article MM12656 for more information"
the presenter on the webinar stated that, while if a patient has a positive FOBT or Cologuard, they could still have a screening colonoscopy, BUT she didn't have any guidance (at the moment) regarding how to list the diagnoses.